Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 589, 177-178 (2021)
doi: https://doi.org/10.1038/d41586-021-00031-0
Updates & Corrections
-
Update 08 January 2021: This story has been updated with findings from a preprint that suggests the Pfizer–BioNtech vaccine is effective against a mutated form of the SARS-CoV-2 virus.
References
Xie, X. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.01.07.425740 (2021).
Tegally, H. et al. Preprint at medRxiv https://doi.org/10.1101/2020.12.21.20248640 (2020).
Davies, N. G. et al. Preprint at medRxiv https://doi.org/10.1101/2020.12.24.20248822 (2020).
Plante, J. A. et al. Nature https://doi.org/10.1038/s41586-020-2895-3 (2020).
Andreano, E. et al. Preprint at bioRxiv https://doi.org/10.1101/2020.12.28.424451 (2020).
Greaney, A. J. et al. Preprint at bioRxiv https://doi.org/10.1101/2020.12.31.425021 (2021).